tiprankstipranks
Omega downgraded to Market Perform from Outperform at Raymond James
PremiumThe FlyOmega downgraded to Market Perform from Outperform at Raymond James
3M ago
Omega Therapeutics price target lowered to $4 from $9 at Piper Sandler
Premium
The Fly
Omega Therapeutics price target lowered to $4 from $9 at Piper Sandler
3M ago
Omega Therapeutics provides updated MYCHELANGELO I data
Premium
The Fly
Omega Therapeutics provides updated MYCHELANGELO I data
3M ago
Omega Therapeutics announces publication of preclinical data of OTX-2002
PremiumThe FlyOmega Therapeutics announces publication of preclinical data of OTX-2002
5M ago
Omega Therapeutics appoints Nelson as SVP of Research
Premium
The Fly
Omega Therapeutics appoints Nelson as SVP of Research
6M ago
Omega Therapeutics price target lowered to $6 from $7 at Chardan
Premium
The Fly
Omega Therapeutics price target lowered to $6 from $7 at Chardan
7M ago
Omega Therapeutics appoints Certel as Chief Business Officer
PremiumThe FlyOmega Therapeutics appoints Certel as Chief Business Officer
9M ago
Omega Therapeutics presents new preclinical data at ASGCT 2024
Premium
The Fly
Omega Therapeutics presents new preclinical data at ASGCT 2024
10M ago
Omega Therapeutics sees cash runway into 1Q25
Premium
The Fly
Omega Therapeutics sees cash runway into 1Q25
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100